Public Profile

Biocon

Biocon Limited, a leading biopharmaceutical company headquartered in Bengaluru, India, has established itself as a key player in the global biotechnology industry since its founding in 1978. With a strong focus on biopharmaceuticals, biosimilars, and novel biologics, Biocon operates across major regions including Asia, Europe, and North America. The company is renowned for its innovative products, particularly in the fields of diabetes, oncology, and autoimmune diseases. Biocon's commitment to affordability and accessibility sets it apart, making significant strides in providing high-quality healthcare solutions. Notable achievements include the launch of India's first biosimilar monoclonal antibody and recognition as a pioneer in the biosimilars market. With a robust pipeline and a reputation for excellence, Biocon continues to shape the future of biotechnology on a global scale.

DitchCarbon Score

How does Biocon's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

40

Industry Average

Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

14

Industry Benchmark

Biocon's score of 40 is higher than 98% of the industry. This can give you a sense of how well the company is doing compared to its peers.

98%

Biocon's reported carbon emissions

In 2024, Biocon reported total carbon emissions of approximately 125,922,000 kg CO2e, comprising 23,273,000 kg CO2e from Scope 1 and 25,307,000 kg CO2e from Scope 2 emissions. The company also recorded Scope 3 emissions of about 77,342,000 kg CO2e. This marks a significant increase from 2023, where total emissions were around 131,095,000 kg CO2e. Biocon has set an ambitious target to achieve a 20% reduction in Scope 1 and Scope 2 emissions by 2032, having already achieved a 14% reduction from the baseline year of FY 2022. This commitment reflects the company's proactive approach to climate action and aligns with industry standards for greenhouse gas (GHG) emissions management. Overall, Biocon's emissions data and reduction initiatives demonstrate a commitment to sustainability and responsible environmental stewardship, positioning the company as a leader in the biopharmaceutical sector in India.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

2021202220232024
Scope 1
55,997,000
000,000,000
00,000,000
00,000,000
Scope 2
127,530,000
00,000,000
00,000,000
00,000,000
Scope 3
-
00,000,000
00,000,000
00,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Biocon's primary industry is Chemicals nec, which is medium in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Biocon is headquartered in IN, which has a rank of very high, indicating very high grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Biocon is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Similar Organizations

Ipca Laboratories

IN
Medical, precision and optical instruments, watches and clocks (33)
Updated about 23 hours ago

Zydus Lifesciences

IN
Medical, precision and optical instruments, watches and clocks (33)
Updated 1 day ago

Mankind Pharma

IN
Medical, precision and optical instruments, watches and clocks (33)
Updated 1 day ago

Glenmark Pharmaceuticals

IN
Medical, precision and optical instruments, watches and clocks (33)
Updated about 23 hours ago

Aurobindo Pharma

IN
Medical, precision and optical instruments, watches and clocks (33)
Updated 5 days ago

Piramal Pharma Limited

IN
Chemicals nec
Updated 5 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers